Menu Back to DIA-Middle-East-Regulatory-Conference

Overview

This is the 12th DIA Middle East Regulatory Conference (MERC) in partnership with the Middle East Regulatory Network (MERN). The conference will bring together most authorities from the Middle East region and discuss the hot topics in the region, such as serialisation and life cycle management. Recent developments at country-level are also discussed. This conference is one of its kind and takes place biennially. It has grown rapidly over the past years and early registration is recommended.

Our Middle East Regulatory Conference programme committee, pulled together their thoughts on regulatory progress made in countries across the region. Examples include: Issue of fast track regulation in Egypt, and Update on pricing regulations in Lebanon. View Infographic

View the Global Forum articles from the 2013 MERC & 2015 MERC

 

Featured topics

The programme is under development and will be updated frequently. We recommend visiting the page for updates.

  • Updates from authorities in operating in the region
  • Facilitated regulatory pathways
  • Life cycle management
  • Safety Labelling updates
  • Pharmacovigilance in the Middle East
  • Who should attend?

    The conference offers the opportunity for key stakeholders active or interested in this diverse and changing region, including representatives from regulatory agencies, ministries of health, local and multi-national pharmaceutical companies, to meet to exchange views, discuss topics of interest and identify actions to increase patient access to new and improved medicines and therapies.

    Program Committee

    • Kerstin  Ahrendt-Soelter
      Kerstin Ahrendt-Soelter Director Regulatory Affairs International
      Biotest AG, Germany
    • Donia   Al Bastaki
      Donia Al Bastaki Head of Registration Department, Pharmaceutical & Herbal Medicines Registration
      Ministry of Health, Drug and Food Control, Kuwait
    • Tamara  Al Rabi
      Tamara Al Rabi Country Regulatory Head
      Pfizer, Jordan
    • Haitham Saad Al-Zuhair
      Haitham Saad Al-Zuhair Regulatory Affairs Director
      Janssen-Cilag, Saudi Arabia
    • Hassaan S  Alwohaibi
      Hassaan S Alwohaibi Director of Products Licensing Department - Executive Department of Licensing
      Saudi Food and Drug Authority, Saudi Arabia
    • Ihab  Attia
      Ihab Attia RAWG Chair
      Eli Lilly (suisse) S.A., United Arab Emirates
    • Adele  Choueiry
      Adele Choueiry Head, Regulatory Affairs, Levant Region; Lebanon Regulatory Working Group Chair
      Novartis , Lebanon
    • Paul  Dearden
      Paul Dearden Director, Regulatory Policy & Intelligence
      AbbVie, United Kingdom
    • Samia  Farhan
      Samia Farhan Director Regulatory Affairs
      Abbvie, Egypt
    • Greg  Jordinson, MSc
      Greg Jordinson, MSc Associate Director, Global Regulatory Affairs
      Janssen R&D, United Kingdom
    • Mounay Hussein Khafaja, PharmD, MSc
      Mounay Hussein Khafaja, PharmD, MSc Regulatory Affairs Director & Regulatory Center of Excellence, IRWG Group Chair
      Merck, Lebanon
    • Sarah  Maqseed
      Sarah Maqseed Health Authority Advisors
      KFDA Kuwait Drug and Food Control Administration, Kuwait
    • Marloes  van Bruggen, MS
      Marloes van Bruggen, MS Regulatory Program Manager
      F.Hoffmann-La Roche Ltd., Switzerland
    • Nadine  Otin
      Nadine Otin
      LEEM, France
    Load More

    Digital Learning Catalog

    eLearning Catalog Cover
    Download